Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

Agenda: 6 in-depth conferences in one

Day One

Keynote Opening
8:30AM - 8:35AM
Welcome Address

eyeforpharma Paul Simms Chairman eyeforpharma

8:35AM - 9:15AM
Ready for Healthcare Leadership - How Pharma embraces a New Customer Engagement Paradigm
  • Discuss industry implications of the shift to value-based care and learn how pioneering leaders position pharma companies to thrive in the complexity of the future healthcare ecosystem
  • Define the value of pharmaceutical innovation through the lens of the patient journey and lay the foundation to partner with healthcare delivery to support patient population management
  • Explore how to demonstrate transparency to build trust with patients, physicians and politicians

Otsuka Kabir Nath President & CEO Otsuka North America

Shire Perry Sternberg EVP & Head U.S. Commercial Shire

Kaiser Permanente Andrew McCulloch President- Kaiser Foundation Health Plan & Hospitals Northwest Region Kaiser Permanente

Moderator: National Health Council Marc Boutin CEO National Health Council

9:15AM - 9:45AM
Real Human Connection – A healthcare marketer's new superpower
  • In today's world, it appears that everything is “social” and “connected,” yet what does “being connected” even mean when it comes to healthcare?
  • Learn from real-world examples of how different healthcare stakeholders connect around patients and their needs

Shire Eric Cline Director Marketing US Neuroscience Business Unit Shire

UCB Dakar De La Cruz Senior Brand Manager Epilepsy Patients Initiatives UCB

AstraZeneca Pharmaceuticals Lise Hall Associate Director of Consumer Marketing Lung Cancer Franchise AstraZeneca Pharmaceuticals

Moderator: Snow Companies Chemelle Evans Vice President Snow Companies

9:45AM - 10:00AM
Awards Finalist Announcement: Most Valuable Patient Initiative
10:00AM - 10:30AM
Exhibition & Networking Coffee Break
10:30AM - 11:00AM
Patient Centricity as a Journey: Spearheading Cultural Change in a Global Pharma Organization
  • Hear leadership lessons and best practices on how to drive transformative cultural change, break organizational silos and foster a company-wide ethos of “patients first”
  • When vision meets determination: How can you initiate the success of a patient-focused mindset through a mix of top-down motivation and bottom-up actions?
  • Learn about the relationship between business growth and patient focus and how it impacts your stakeholder management

Merck Julie Gerberding EVP & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health Merck

11:00AM - 11:30AM
Delivering Impact through Customer-Centric Partnerships

The U.S. healthcare marketplace has undergone dramatic changes, including the shift in power away from physicians, and towards large payers and provider systems as they take on more risk and want demonstrable value. This has made pharma’s traditional model less relevant.

In response, pharmaceutical companies must reinvent the way they go to market by focusing on the unique needs of complex corporate customers to create a customer-centric engagement strategy, including:

  • Customer insights for complete local healthcare markets, including all stakeholders’ needs and interactions
  • Marketing and value propositions that stress the impact on health and value metrics
  • Expansion to dozens of roles that can work as a coordinated team
  • Objectives that align multiple functions in the organization

Some of this is being attempted, with variable success. We will outline a series of “no regret moves” to shift from brand-centricity to a customer-centric way of operating.

ZS Associates Pratap Khedkar Principal ZS

ZS Associates Paul Darling Principal ZS

11:30AM - 12:10PM
Accelerating Bio-Pharmaceutical Innovation in the 21st Century: An Emergent Ecosystem
  • From Cambridge to San Diego: Hear life science leaders who shape the collaborative ecosystem that is shaping up for faster development of tomorrow's cures amongst multiple stakeholders
  • “Distributed” Research: Harness the power of partnerships to accelerate development, standardize frameworks and build open platforms for the in- and outflow of knowledge between partners
  • Take charge of Innovation: Explore novel approaches to finance biopharmaceutical innovation for high-cost, breakthrough medications

Johnson & Johnson Innovation, JLABS Melinda Richter Head Johnson & Johnson Innovation, JLABS

Novo Nordisk Eddie Williams Former SVP BioPharmaceutical Novo Nordisk

Transcelerate Dalvir Gill CEO Transcelerate

12:10PM - 1:25PM
Exhibition & Networking Lunch Break
1:25PM - 1:35PM
Awards Finalist Announcement: Most Valuable HCP Initiative
1:35PM - 2:05PM
It's more than 'the Right Thing to Do': Embrace Patient Centricity as your Key Commercial Focus
  • Learn about the relationship between business growth and patient focus and how the sweet spot impacts your stakeholder management
  • Steer your company's patient focus out of the buzzword land through measurement, cultural training, and executive commitment
  • Explore metrics to reveal the impact of patient-centric initiatives, including performance indicators that can guide your line management
  • Understand where to expand your business offering and customer perspective to truly service patients with everything you do

Pfizer Innovative Health Andy Schmeltz Senior Vice President of Patient & Health Impact Pfizer Innovative Health

2:05PM - 3:10PM
Pharma-only Workshops

Hosted by:

Snow Companies, Everyday Health Professional, QuintilesIMS, Salesforce & Accenture, Sudler Science and Learning & Ogilvy CommonHealth Medical Education

Snow Companies
Everyday Health Professional
Quintiles_IMS
Salesforce & Accenture
Sudler Science and Learning & Ogilvy CommonHealth Medical Education
3:10PM - 3:30PM
Exhibition & Networking Coffee Break
Customer Experience
Patients as Partners
Digital Transformation
Medical Affairs
3:30PM - 3:35PM
Chairman Opening
Chairman Opening
Chairman Opening
Chairman Opening
3:35PM - 4:00PM
Redefining the Customer and Address the Challenges in Providing the Service They Need
  • Learn to navigate highly-matrixed organizations to address potential gaps in delivering a consistent customer experience, regardless of customer segmentation
  • Build a new standard of customer service in the healthcare industry
  • Exceed customer expectations by providing end-to-end service in real time, with real people

Pfizer Tolga Tanguler President- Rare Diseases Pfizer

Patient Advocacy 2.0: Manage Local Customer Engagement from pre-to post launch
  • Strengthen patient advocacy internally as a strategic business function that is guiding the development of unmet needs, inspiring scientist internally, understanding patient expectations around your products and improving patient experiences post-launch
  • Prioritize external visibility, commitment and engagement, go beyond financial backing and enter dedicated alliances with advocacy groups (i.e. to help educate nonprofits on running their operations to sustainably support patient needs)
  • Conduct outreach initiatives and a serious of authentic interactions to deepen bonds between patient groups and your teams

BMS Teresa Bitetti SVP Head US Oncology BMS

How to Do Digital Differently: The "3D"-Script for Pharma Marketing
  • Discover how to effectively engage with patients when it matters most; design customer experiences that align content and media to build real relationships, deliver experiences consistently and superbly
  • Go beyond the patient journey and learn how to inspire patients as they move through the care cycle of detection, diagnosis, treatment, and recovery
  • Get the most out of your commercial model, grow your organization's digital quotient and become the active sharper of patient's care

Google David Blair Head of Industry- Health Google

Make medical the link between R&D and commercial
  • Discuss how and when Medical should become involved in early-stage projects and Life-cycle management
  • Explore the important role of patient centricity as an essential foundational component for collaboration
  • Identify opportunities to improve partnership effectiveness

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

4:00PM - 4:30PM
Maximizing the Potential of Your Pipeline by Utilizing Signals Intelligence to Align with the Treatment Decision Journey and Patient Desired Outcomes
  • Improve health outcomes by uncovering real, perceived and hidden barriers that define therapeutic value.
  • Drive pipeline optimization by aligning your portfolio with patient behaviour, HCP preferences, and choices of care – all critical to a successful launch.
  • Optimize patient adherence by probing real-world attitudes and sentiment toward treatment regimens and patient engagement approaches.

Signals Kobi Gershonim Co-Founder & Chief Research Officer Signals Analytics

Talkin' About My Generation: Connecting with Boomers, Xers and Millennials Around Their Health
  • Communicating with generations that have very different styles
  • Old School Can be New School: How traditional methods can apply to new generations
  • Are you in it for the long haul? Avoiding disposable relationships and building bridges across all generations
  • Results from a recent consumer survey on generational differences and similarities

Health Advocacy Strategies Jean McCoy SVP Strategy & Innovation Health Advocacy Strategies

Identifying HCPs by Name at Your Website

What happens when you solve the 20 year old problem of anonymous visitors to your website? You get:

  • An entirely new level of visitor insight
  • The ability to deliver truly customized and relevant content and services
  • The ability to extend an engagement beyond just a website session
  • A completely new approach to ROI calculation

In this session we will present data from a range of pharma sites who are answering these exact questions.

DMD Marketing David Reim Chief Product Officer DMD

The Good, The Bad and the Necessary
  • A review of success rates in recent drug launches
  • Look at where launches haven't gone well and where RWE could have played a role in mitigating this… The Bad
  • Building an Integrated Medical Plan to prepare for success. “Begin with the End in Mind”… The Good
  • The resource versus demand challenge and the consequent benefit of outsourcing… The Necessary

INC Research Janet Baldwin Vice President, Real World and Late Phase INC Research

4:30PM - 5:10PM
Panel: In our new landscape, how do we now know if a rep is successful?
  • How to define the KPIs that are needed to track sales rep performance, and push the rep to focus on the patient instead of the metrics
  • Reward your reps for prioritizing what your customer really want, and satisfy their long term objectives
  • Determine exactly what new talents are needed in order to tighten the requirements for training and avoid waste or duplication of effort

UCB David Fortanbary US Commercial Lead, Performance Training UCB

Roche Diabetes Care Jay Graves Vice President of Sales Roche Diabetes Care

Panel: Partner with your patients to develop novel patient-reported outcome (PRO) assessment tools
  • Use PRO to understand not only what's the matter with patients but what matters to your patients
  • Hear survey data from patients as to how to effectively collect PRO, leverage patient groups for PRO qualification and draw on patient-led data collection in the design of novel PROs
  • Improve PRO reliability around primary endpoints to facilitate labeling claims and approval, increase patient satisfaction and compliance

Alzheimer's Disease International Kate Gordon Policy Advisor Alzheimer's Disease International

Pfizer Roslyn Schneider Global Patient Affairs Lead Pfizer

Luck Fupus MarlaJan Wexler Patient, Lupus Advocate and Blogger Luck Fupus

Panel: The Power of Integrating Digital across all aspects of your organization
  • Discover the benefits of a customer experience that's continuously supported through digital channels
  • Maximize commercial profitability by employing new digital capabilities to support your business objectives, and set yourself apart from other mHealth offerings
  • Optimize the current digital capabilities and align them with the functions of traditional channels to stay ahead of the game

TEVA Christopher Pitcherella Director, Clinical Trial Innovation | Global Clinical Operations TEVA

Johnson & Johnson Joshua Palau Senior Director Digital Innovation, Social Media and Search Johnson & Johnson

Joyce Ercolino Digital Business Leader & Strategist  

softserve Matt Kollmorgen Vice President of Digital Transformation Group Soft Serve

Panel: Define a new Medical operating model to align with Commercial, Market Access and R&D
  • Understand what internal stakeholders think about their relationship with Medical and the emergence of Medical as a strategic partner
  • Where should medical reside - independently, within R&D, or Commercial?
  • Create a reporting and management structure that meets the needs for a new approach to Medical Affairs

GlaxoSmithKline Kate Knobil Chief Medical Officer, Pharmaceuticals GSK

Medical Affairs Professional Society Kirk Shepard President Medical Affairs Professional Society;
Eisai Pharma & Senior Vice President, Head of Global Medical Affairs Oncology Eisai Pharma

Amgen Rosh Dias Vice President, Global Scientific Affairs Amgen

5:10PM - 5:40PM
The Future-Proof Commercial Team

In this session, we will discuss industry feedback and thought leadership on:

  • The impact of patient-centric transformation on the industry, and organizational barriers to transformation
  • The relationship between patient centricity and commercial models and expectations for future needs
  • The role of technology in enabling continuous evolution and agility across the organization

Pegasystems Ed Chase Business Line Leader, Life Sciences Pegasystems

Delivering Results Through Patient-Centricity: A Look at What Works & Why
  • Thinking differently about what insights you truly need to become patient-centric
  • Practical and innovative ways companies are transforming the way they develop education and support programs to address patient needs
  • Discover how companies outside of pharma are transforming their businesses through customer engagement and how this can be applied to our industry

Sentient Jeff Rohwer Managing Director, Strategy & Innovation Sentient

Digital Transformation from the Inside Out and Upside Down
  • Understand how human science and culture contribute to the design and success of transformative experiences
  • Explore how successful transformation and experiences are driven by organizations whose internal presence mirrors their external presence
  • Attendees will gain a new perspective on how to guide transformation and to capitalize on their own skills to create positive transformations

Cognizant Life Sciences Will Reese President Cadient & Chief Innovation Officer Cognizant Life Sciences

Pharma Collaboration for Transparent Medical Information
  • HCPs need quick, relevant, accurate, scientifically-balanced medical information to enhance patient care
  • phactMI is a consortium comprised of MI departments of multiple pharmaceutical companies to address this need
  • phactMI.org provides an easy access “one stop” to information on drug interactions, stability/compatibility, and dosage and administration… and HCPs can contact and engage with dedicated MI specialists

phactMI Patrick Reilly CEO phactMI

5:40PM - 6:05PM
Customer excellence: the key to commercial excellence
  • Create a positive customer experience and ensure you retain them through a synchronized strategy at every touch point
  • Align the way in which you treat your customer across all areas of your organization in order to provide the most seamless experience possible
  • Blend all your channels in ensure you are speaking to your customer in one harmonious voice

EMD Serono Jon Barrett VP Oncology Marketing EMD Serono

Lessons on Understanding and Acting on Patient Concerns
  • Reveal the methods Sanofi used to systematize the acquiring of patient input, and the methods used to operationalize it
  • How does Pharma's approach align with other industries; lesson's learned?
  • Showcase how to measure the impact of acting on patient concerns, and create a continuum between research and development

Sanofi Anthony J. Yanni Global Head, Medical Intelligence and Patient Perspectives Sanofi

Leveraging Digital: Navigating Digital Trends and Technologies to Maximize Positive Outcomes for Patients
  • A look at the adoption of digital across all industries
  • Understand why digital will impact healthcare and How can patients benefit
  • What a Pharma company can do to address the digital trends and what are the emerging technologies
  • What could the pharma company of the future look like

Takeda Nicole Mowad-Nassar VP of External Collaborations Takeda

The Doctor is in (and out): Medical Affairs' evolution from an internal role to an external one
  • Understand the evolving role of medical affairs in pharma
  • Explore the benefits and challenges of using internal medical spokespeople for external communications
  • Embrace the potential for medical affairs' new role through a case study

GlaxoSmithKline Leonard Friedland Vice President, Director Scientific Affairs and Public Policy, Vaccines North America GSK

6:05PM - 7:30PM
Exhibition & Networking

Day Two

Customer Experience
Digital Transformation
Commercial Model Innovation
Medical Affairs
8:30AM - 8:35AM
Chairman Opening
Chairman Opening
Chairman Opening
Chairman Opening
8:35AM - 9:00AM
Session begins at 9am – please join another room
Create a winning partnership through collaboration and innovation
  • Explore how the partnership with technology companies can revolutionize your business model and boost commercial success
  • Understand how you can advance your patient-centric model with the help of multiple players
  • See how Novartis is partnering with newer companies entering the pharma space to create value for patients

Novartis David Lennon VP & Franchise Head, US Oncology- Lung, Melanoma and Neuroendocrine Tumours Novartis

Your Company needs to be Disrupted: Leverage Corporate Activism for Quality Control and Value Creation
  • When tweaking no longer cuts it: Hear why Sanofi decided to take unprecedented steps to address quality issues through a business transformation rooted in collaborative tools and technologies
  • Incubate change wherever you sit: Hear views from both floor staff and executives how to disrupt a company and re-ignite productivity with tools of behavioural change and social engagement
  • Securing Buy-In: How to manage executive support, show metrics and convince your leadership to embrace the power of diverse networks to once-and-for-all replace pharma's (patriarchal) corporate hierarchies

Sanofi Pasteur Christine Richards Director SP Quality Academy Sanofi Pasteur

Collaborate with Commercial to create a compliant and patient-focused Medical Affairs strategy
  • Identify appropriate cross-functional stakeholders for coordination and alignment
  • Ensure independence and integrity of Medical Affairs and Commercial functions
  • Enable effective and compliant information sharing/communication

Astellas Pharma Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas Pharma

Astellas Karen Lowney Executive Director, Global Compliance, Privacy & Transparency Astellas

9:00AM - 9:30AM
What’s in a name?
  • Explore why your name is critical to the success of your brand
  • Learn about the .health extension that launches this July

Followed by a panel discussion with:

  • Erin Byrne, Chief Client Officer at greyhealth group
  • Melissa Lederer, Head of Marketing at MATTER
  • Matthew Murphy, Director of Digital Health Innovation at Boston Children's Hospital
  • José Ignacio Rasco, CEO at dotHealth

dotHealth José Ignacio Rasco CEO .health

The Freedom to Fail: Using predictive analytics to simulate, experiment with and optimize your approach to marketing
  • Test it before you try it by using simulation-based modeling
  • Arm yourself with the data to validate new approaches
  • Stop investing in things only because ‘we did it last year'
  • Move from instinct to evidence as you plan for 2018

inVentiv Health Communications Patrick Richard Managing Director Data Science inVentiv Health Communications

inVentiv Health Communications Leigh Householder Managing Director of Innovation inVentiv Health Communications

Challenging pharma's traditional sales model to drive revenue, access, and customer experience
  • Learn about a service model which has proven an increase in revenue across the lifecycle of a brand
  • Access to targeted accounts reach nearly 100%
  • A clear mission to serve patients improves job satisfaction and retention among service representatives
  • Proven value to patients, physicians and office staff over traditional representatives

Ashfield John Gerow Global Head, Customer Service Model Ashfield

Hire the right skillsets for the new medical affairs paradigm
  • Define recruitment and training strategies to meet your medical affairs needs
  • Build soft business skills within medical specialist talent
  • Create a team that can execute RWE and data-centric engagement strategies

- Stanislev Glezer former Vice President, Medical Affairs Novo Nordisk

9:30AM - 9:55AM
Sales rep 2.0: A new portrait of a customer facing role
  • Upskill your rep to make the most of every customer interaction, in order to not waste any time and ensure commercial success
  • Define the role the new rep has to take in order to support new growth and training
  • Identified gaps in your field force in order to ensure you have the strongest team when facing the customer

Roche Diabetes Care Jay Graves Vice President of Sales Roche Diabetes Care

Listen to what the patient is saying- they are after all depending on you.
  • Utilize patient data to make more informed commercial strategy decisions
  • Leverage insights from the front lines: Re-define patient focus as customer service and strategically optimize patient engagement and field-based promotions based on front-line experiences
  • Hear how patient input can add value and profitability to your customer interactions and without a doubt improve patient outcomes

Alnylam Pharmaceuticals Mark Baglin Vice President of Global Marketing Alnylam Pharmaceuticals

Seize the day: teach your commercial teams to leverage untapped opportunities with patient-centric selling
  • Collaborate with different internal partners and stakeholders, in order to ensure that customer engagement interactions are impactful to the customer
  • Become an educator alongside your selling, build trust and improve patient engagement
  • Case Study: A look at value over volume selling, a new kind of customer engagement.

Takeda Pharmaceuticals USA Heather Dean National Head Specialty Sales & Accounts Takeda Pharmaceuticals USA

The Competent Medical Affairs Professional
  • Discuss the emerging role of professional competencies (applied knowledge, skills and behaviors) in bridging the business needs with the scientific rigor of the medicines development process
  • Understand how to benchmark the proposed competency profiles in medical affairs
  • Appreciate the value of a multi-sectorial collaboration (academia, professional associations, pharmaceutical industry) to improving performance in the Medical Affairs function

IFAPP Honorio Silva President IFAPP

9:55AM - 10:20AM
Patient-Centricity…A practical approach for implementation at a brand and corporate level
  • Apply patient-centric approaches to brand planning
  • Facilitate cultural mindset shift by setting a corporate framework for patient-centricity
  • Prioritizing quick wins and longer term approaches for transformational change

Sunovion John Jacoppi Executive Director New Product Planning Sunovion

Maximize the capabilities of your commercial teams through a greater understanding of Analytics, CRM and CLM
  • Leverage the insights gained from analytics, CRM and CLM for a more personalized interaction
  • Revolutionize sales performances, by increasing value to HCPs by responding to market changes and prescribing habits
  • Develop a segmentation strategy informed by data to ensure you're personalizing your interactions with your customer and content

Abbvie Laura Barry Senior Director Customer Insights, Analytics and Experiences Abbvie

Customer-Centricity is key, are you doing enough?
  • Embed a customer-centric mindset across the whole organizations and across all commercial functions to add value and improve retention and resources for them and patients
  • Become the kind of partner your organized customer wants, and work together towards solutions for outcome optimization and improved patient experience
  • Create a cultural mind-shift in your organization that puts impactful customer programs and services first

Astellas Peter Sandor Head of Oncology Marketing Astellas

How to create a patient-centric Medical Affairs unit
  • Define best practice to engage patients, understand their needs and create patient-centric medical information exchange
  • How to work progressively with patients to gather data
  • Can Medical Affairs become the patient centricity function?

Pfizer Roslyn Schneider Global Patient Affairs Lead Pfizer

10:20AM - 10:40AM
Exhibition & Networking Coffee Break
Customer Experience
Pharma's Triple Aim
Commercial Model Innovation
Medical Affairs
10:40AM - 11:20AM
Panel: Differentiate your offerings through co-creation and superior customer experience
  • Meet customer and patients need, provide unique offerings and get yourself ahead in the marketplace
  • Drive sustained engagement through co-creation of patient support programs and superior consumer experience
  • Hear from a panel of commercial leaders how to define the relationship between business strategy and patient focus

Sanofi Pasteur Kasia Hein-Peters Vaxelis (PR51) Marketing Head Sanofi Pasteur

Speaker_Logo Heidi Floyd Author / Patient / Advocate / Speaker  

Aqua Pharmaceuticals Jim DeMaioribus Vice President Aqua Pharmaceuticals

Panel: ‘Where Rubber hits the Road': Move from words to actions on Patient Centricity
  • Move from “Why” to “How to” and realize patient centricity not just out of moral obligation, but as a core objective for your organization
  • Discover how your teams can reach the ‘sweet spot' between patient and profit, achieving high trust and credibility, business growth and better outcomes for all

Johnson & Johnson Ramana Sonty Director- Global Medical Organization Johnson & Johnson

Pfizer Inc Nisith Kumar Director, Global Patient Affairs Pfizer Inc

Global Alzheimer's Platform Foundation Kate Zhong Chief Strategy Officer Global Alzheimer's Platform Foundation

Tonic Life Communications Maryellen Royle Global CEO Tonic Life Communications

Panel: A holistic commercial view: integrate your sales and marketing teams in order to achieve true commercial excellence
  • Take your business to the next level with common objectives and incentives to promote a collaborative culture across sales and marketing
  • Encourage sales and marketing to align their common interests and impact and influence behavioural change within your organization
  • Speak with one voice: Integrate M&S in order to work in synch with your customers' needs
  • Supplement commercial functions, with foresights and forecasting to help them know what will actually benefit the patient
  • Aligned the skills of your customer facing roles so that you approach customer engagement strategy with a unified front

Shire Chris Sellin Head of Operational Excellence & Analytics Shire

Zephyr Health William King Founder Zephyr Health

Takeda Pharmaceuticals USA Heather Dean National Head- Specialty Sales & Accounts, Specialty Business Unit Takeda Pharmaceuticals USA

Panel: Proactive communication of scientific and health economic information
  • Expert legislative and regulatory guidance relating to scientific communication by medical affairs personnel
  • An update on FDAMA 114 and the proactive communication of health economic information
  • Recent changes to communication of scientific and health economic information of pipeline products and indications
  • Recommendations from the Academy of Managed Care Pharmacy Partnership Forum on Pre-approval Information Exchange

Genentech Dana Evans Director for Patient Access, Collaboration and Exchange Genentech

Aetna Elizabeth Engelhardt Head of Specialty Strategy & Clinical Management Aetna

Academy of Managed Care Pharmacy (AMCP) Soumi Saha Assistant Director of Pharmacy & Regulatory Affairs Academy of Managed Care Pharmacy (AMCP)

11:20AM - 11:50AM
The Rise Of Consumerism In Healthcare: Engaging Your New Customer
  • The rise of consumerism in healthcare and its implications on your patient engagement strategy
  • A proven approach for going beyond the pill to engage patients as active participants in their care
  • The importance of looking to other industries that are already delivering 1:1 customer experiences
  • The future of the industry - how to leverage data and analytics for hyper-personalization as well as new innovations including artificial intelligence and voice

Mobiquity Ashkan Afkhami VP & GM, Healthcare Mobiquity

Mobiquity Mike Welsh Chief Creative Officer Mobiquity

Delivering Value through Patient Centric Transformation
  • Discuss how to be adequately prepared across the commercial continuum for Market Access and Pricing evolution that is rapidly moving toward more value based, outcomes driven solutions.
  • Understand how to stand out based on Patient services programs that are increasingly the differentiating factor driving patient centricity and greater customer experience.
  • Learn how your organization can be better positioned within a multi-stakeholder, patient-centric, digitally enabled environment.

EY Susan Garfield Principle EY

Innovation in Provider Access: A New Era of Outcomes
  • Identify the current challenges presented to field forces by the face-to-face push sales model given decreased access with healthcare providers.
  • Explore and discuss the new solutions that add pull to sales efforts and early successes of these solutions.
  • Discuss the potential for the future. How can the life sciences further diversify their channels? What other pressing HCP and life science issues can be solved using technology?

Outcome Health Roger Sawhney Senior Vice President of Life Sciences Strategy and Business Development Outcome Health

Can Medical Affairs stay relevant in an era of emerging technologies to help the HCP?
  • Appreciate how healthcare professionals' disease information needs are changing
  • Can technology help Medical to stay relevant, and meet increasingly high expectations of HCPs, or will it become a competitor?
  • Envisage what the future of medical could look like in this rapidly changing world of technology

Bristol-Myers Squibb Lav (Bobby) Parvathenani Specialty Medical Information Lead, US Medical Bristol-Myers Squibb

11:50AM - 12:50PM
Exhibition, Networking & Work Lunch Roundtables
11:50AM - 12:50PM
Interactive Roundtables – Lead the discussion

Moderated by industry experts, you can join fellow attendees in one of 5 interactive roundtables providing you with the opportunity to go in-depth into the challenges which you’re faced with on a daily basis – you guide the agenda.


Diversity is an Opportunity: the benefits of engaging with diverse patient populations across R&D and commercial strategies

  • Discuss how to reach out to patient communities of all backgrounds
  • Improve your understanding of the needs of patients from all backgrounds, to develop support services that meet those needs at the site of care

Moderated by: Melva Covington, Senior Director, Head of Field Based Medical Strategy, Sanofi

Felicia S. Johnson, Patient Advocate


Digital Health Marketing – Challenges, Opportunities and Best Practice

  • Join industry leader, Mark Bard, co-founder of the Digital Health Coalition in an open discussion on the future of digital health marketing
  • Learn from your peers on the nuances of the existing landscape including market trends, regulatory concerns (and solutions) and best practice examples.

Moderated by: Mark Bard, co-chair and founder, Digital Health Coalition


Redefining Sales Operations as a Strategic Function

  • Discuss research from the Sales Management Association on how high-performing sales operations functions define objectives, allocate resources and maximise quality and efficiency
  • Hear how to redefine of sales operations to become a strategic imperative, not just a tactical function

Moderated by: Bob Kelly, chairman, The Sales Management Association


Leave the Silo: Fostering Cross-Company Partnerships to Deliver Real Change for Patients

  • Join a discussion on how as an industry we can join together to drive real change
  • Hear about how The Aurora Project is helping to guide patient-centric change across pharma and what you can do to get involved

Moderated by: Jill Donahue, co-founder of The Aurora Project


Women in Pharma

  • Join industry leader, Laurie Cooke, CEO of the Healthcare Businesswomen’s Association in an open discussion on women in Pharma
  • Gender Diversity is no longer a women’s issue, it’s a business issue. Business can get there faster by partnering; greater partnership means greater progress.

Moderated by: Laurie Cooke, CEO, Healthcare Businesswomen's Association


Medical Affairs: Education and Training for an effective performance

  • Discuss the professional competencies for biomedical professionals to leverage their contributions within the organization
  • Discuss the initiatives developed by IFAPP and King’s College London for professional certification in Medical Affairs

Moderated by Honorio Silva, President, IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine)

12:50PM - 1:20PM
The Modern Marketer: how to stay ahead in a competitive and evolving landscape
  • Work cross-functionally with your teams to maximize your commercial capabilities
  • Become a reliable supplier and valuable partner to your customers
  • Understand how to identify areas of mutual gain with IDNs to help improve patient outcomes and reduce costs

GSK Kim Murphy VP Global Vaccines Commercialization Leader- Influenza GSK

Proactive Nurse Engagement to Improve the Patient Experience: The UCB Right Start Program Case Study
  • Understand the difference a trusted advocate can make in addressing the unmet needs of patients with chronic conditions throughout their healthcare journey
  • Learn how engaging Nurse Educators to connect patients with the right resources at the right time provided a superior experience and improved patient persistency

UCB Jamie Burks Patient Experience Lead, Patient Value Unit UCB

BLANK Liza Maricle RN, Right Start Nurse Educator  

How Lilly Drives Efficiency and Business Insights through Advanced Forecasting Methodologies

Through this case study example, discover how this leading pharmaceutical organization leveraged advanced Forecasting methodologies and tools to:

  • Increase the Productivity of the Forecasting team
  • Reduce the time to create a forecast by more than 50%
  • Analyze large amounts of data quickly and with more accuracy using advances in technologies
  • Manage multiple data sources, forecasting tools and performance reporting in one common system

Eli Lilly and Company Robert P Draper Sr Director, Lilly BioMedicines Forecasting Eli Lilly and Company

Make companion diagnostics a reality with more collaborative medical & scientific affairs
  • Discover how a coordinated approach between pharmaceutical and diagnostic medical affairs will lead to successful and rapid adoption of a companion diagnostic
  • Identify the various factors influencing the use of a companion diagnostic, and how this then influences the use and performance of the companion therapeutic
  • How to develop an implementation strategy that assures access to the companion diagnostic test at the day of drug launch

Roche Diagnostics Alan Wright Chief Medical Officer Roche Diagnostics

1:20PM - 1:45PM
Session ends. Please join another room
Why Highly Effective Drugs Are Not Enough: An Affordable Solution to Eliminating HCV
  • Develop responses to the problem of undiagnosed Hepatitis C cases globally, and learn that high drug prices are financially toxic to payers and patients and disincentives screening for undiagnosed patients
  • See how Trek is developing affordable and accessible HCV Genotype 1b (G1b), G1, and G2/3 Regimens for under-served populations in middle- and high-income countries  

TREK Therapeutics Ann Kwong CEO TREK Therapeutics

Session ends. Please join another room
Execute a MSL strategy that navigates pro-active engagement and compliance
  • How to add customer value beyond communicating product information
  • Where should you invest to create impactful resources in a landscape of competitive sources of disease information?
  • Learn what steps to take to mature your model of MSL engagement

GlaxoSmithKline Diane McDowell Head, Global Scientific Affairs Oncology GSK

1:45PM - 2:50PM
Pharma-only Workshops

Hosted by:

viihealth, Clarkston Consulting

Vii Health
Clarkston Consulting
Panel: RWE Excellence within Medical Affairs
  • With the deluge of possible RWE sources, how do we develop analytic tools to assess the value of data
  • How can Medical Affairs facilitate the generation of new data?
  • How has the growth in evidence sources changed the importance of KOLs?
  • What compliant strategies can Medical Affairs use to communicate RWE?

Moderator: ghg_greyhealth_group Lynn Vos CEO ghg | greyhealth group

Astellas Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

- Stanislav Glezer Former Vice President, Medical Affairs Novo Nordisk

2:50PM - 3:10PM
Exhibition & Networking Coffee Break
Keynote Closing
3:10PM - 3:20PM
Awards Finalist: Customer Innovator Award & Lifetime Achievement Award
3:20PM - 3:50PM
The Impact of Value-Based Care: How It Will Transform Your Commercial Model
  • Explore the evolution of value-based care in the current healthcare ecosystem
  • Prepare to address the intersection of patient consumerism and value-based care to support a new definition of success
  • Examine key considerations to improve commercial uptake in a value-based care environment

McKesson Reagan Tully VP Marketing and Strategy McKesson

3:50PM - 4:20PM
Squaring the Circle: how to drive performance and create success in a values culture
  • Explore the complex launch challenges faced by GSK's newest vaccine Bexsero
  • Find out how GSK integrated Novartis Vaccines in its largest market, while implementing new commercial model changes in terms of HCP interaction
  • Understand how Patrick Desbiens led the integration of legacy and new vaccines teams and created a launch plan
  • Listen to Patrick explain the choices and the learnings on how to achieve success in a strong value-based culture from a year that saw GSK's vaccine sales in the US increase by 12%

GSK Patrick Desbiens Senior Vice President, US Vaccines GSK

4:20PM - 4:30PM
Awards Finalist: Most Valuable Pharma Collaboration
4:30PM - 5:00PM
The Implementation Panel: From Words to Action, How to Become a Pharma Intrapreneur
  • Hear from our panel how you can make actionable change in your organizations through a structured process, behavioral engagement and prospective resource planning
  • Ensure open and reliable communication streams between departments, learn practical steps to break the ‘silo mentality', and institute a collaboration approach that removes barriers long before they become a threat
  • Become the ‘Intrapreneurial change agent' everyone respects, form alliances and manage innovation processes effectively to strengthen your organization from within

GSK Cheryl MacDiarmid SVP & Business Unit Head, Primary Care GSK

Sanofi Sheldon Koenig SVP & Head Cardiovascular Franchise Sanofi

Moderator eyeforpharma Paul Simms Chairman eyeforpharma

Day One

Keynote Opening
8:30AM - 8:35AM
Welcome Address

eyeforpharma Paul Simms Chairman eyeforpharma

8:35AM - 9:15AM
Ready for Healthcare Leadership - How Pharma embraces a New Customer Engagement Paradigm
  • Discuss industry implications of the shift to value-based care and learn how pioneering leaders position pharma companies to thrive in the complexity of the future healthcare ecosystem
  • Define the value of pharmaceutical innovation through the lens of the patient journey and lay the foundation to partner with healthcare delivery to support patient population management
  • Explore how to demonstrate transparency to build trust with patients, physicians and politicians

Otsuka Kabir Nath President & CEO Otsuka North America

Shire Perry Sternberg EVP & Head U.S. Commercial Shire

Kaiser Permanente Andrew McCulloch President- Kaiser Foundation Health Plan & Hospitals Northwest Region Kaiser Permanente

Moderator: National Health Council Marc Boutin CEO National Health Council

9:15AM - 9:45AM
Real Human Connection – A healthcare marketer's new superpower
  • In today's world, it appears that everything is “social” and “connected,” yet what does “being connected” even mean when it comes to healthcare?
  • Learn from real-world examples of how different healthcare stakeholders connect around patients and their needs

Shire Eric Cline Director Marketing US Neuroscience Business Unit Shire

UCB Dakar De La Cruz Senior Brand Manager Epilepsy Patients Initiatives UCB

AstraZeneca Pharmaceuticals Lise Hall Associate Director of Consumer Marketing Lung Cancer Franchise AstraZeneca Pharmaceuticals

Moderator: Snow Companies Chemelle Evans Vice President Snow Companies

9:45AM - 10:00AM
Awards Finalist Announcement: Most Valuable Patient Initiative
10:00AM - 10:30AM
Exhibition & Networking Coffee Break
10:30AM - 11:00AM
Patient Centricity as a Journey: Spearheading Cultural Change in a Global Pharma Organization
  • Hear leadership lessons and best practices on how to drive transformative cultural change, break organizational silos and foster a company-wide ethos of “patients first”
  • When vision meets determination: How can you initiate the success of a patient-focused mindset through a mix of top-down motivation and bottom-up actions?
  • Learn about the relationship between business growth and patient focus and how it impacts your stakeholder management

Merck Julie Gerberding EVP & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health Merck

11:00AM - 11:30AM
Delivering Impact through Customer-Centric Partnerships

The U.S. healthcare marketplace has undergone dramatic changes, including the shift in power away from physicians, and towards large payers and provider systems as they take on more risk and want demonstrable value. This has made pharma’s traditional model less relevant.

In response, pharmaceutical companies must reinvent the way they go to market by focusing on the unique needs of complex corporate customers to create a customer-centric engagement strategy, including:

  • Customer insights for complete local healthcare markets, including all stakeholders’ needs and interactions
  • Marketing and value propositions that stress the impact on health and value metrics
  • Expansion to dozens of roles that can work as a coordinated team
  • Objectives that align multiple functions in the organization

Some of this is being attempted, with variable success. We will outline a series of “no regret moves” to shift from brand-centricity to a customer-centric way of operating.

ZS Associates Pratap Khedkar Principal ZS

ZS Associates Paul Darling Principal ZS

11:30AM - 12:10PM
Accelerating Bio-Pharmaceutical Innovation in the 21st Century: An Emergent Ecosystem
  • From Cambridge to San Diego: Hear life science leaders who shape the collaborative ecosystem that is shaping up for faster development of tomorrow's cures amongst multiple stakeholders
  • “Distributed” Research: Harness the power of partnerships to accelerate development, standardize frameworks and build open platforms for the in- and outflow of knowledge between partners
  • Take charge of Innovation: Explore novel approaches to finance biopharmaceutical innovation for high-cost, breakthrough medications

Johnson & Johnson Innovation, JLABS Melinda Richter Head Johnson & Johnson Innovation, JLABS

Novo Nordisk Eddie Williams Former SVP BioPharmaceutical Novo Nordisk

Transcelerate Dalvir Gill CEO Transcelerate

12:10PM - 1:25PM
Exhibition & Networking Lunch Break
1:25PM - 1:35PM
Awards Finalist Announcement: Most Valuable HCP Initiative
1:35PM - 2:05PM
It's more than 'the Right Thing to Do': Embrace Patient Centricity as your Key Commercial Focus
  • Learn about the relationship between business growth and patient focus and how the sweet spot impacts your stakeholder management
  • Steer your company's patient focus out of the buzzword land through measurement, cultural training, and executive commitment
  • Explore metrics to reveal the impact of patient-centric initiatives, including performance indicators that can guide your line management
  • Understand where to expand your business offering and customer perspective to truly service patients with everything you do

Pfizer Innovative Health Andy Schmeltz Senior Vice President of Patient & Health Impact Pfizer Innovative Health

2:05PM - 3:10PM
Pharma-only Workshops

Hosted by:

Snow Companies, Everyday Health Professional, QuintilesIMS, Salesforce & Accenture, Sudler Science and Learning & Ogilvy CommonHealth Medical Education

Snow Companies
Everyday Health Professional
Quintiles_IMS
Salesforce & Accenture
Sudler Science and Learning & Ogilvy CommonHealth Medical Education
3:10PM - 3:30PM
Exhibition & Networking Coffee Break
Customer Experience
Patients as Partners
Digital Transformation
Medical Affairs
3:30PM - 3:35PM
Chairman Opening
Chairman Opening
Chairman Opening
Chairman Opening
3:35PM - 4:00PM
Redefining the Customer and Address the Challenges in Providing the Service They Need
  • Learn to navigate highly-matrixed organizations to address potential gaps in delivering a consistent customer experience, regardless of customer segmentation
  • Build a new standard of customer service in the healthcare industry
  • Exceed customer expectations by providing end-to-end service in real time, with real people

Pfizer Tolga Tanguler President- Rare Diseases Pfizer

Patient Advocacy 2.0: Manage Local Customer Engagement from pre-to post launch
  • Strengthen patient advocacy internally as a strategic business function that is guiding the development of unmet needs, inspiring scientist internally, understanding patient expectations around your products and improving patient experiences post-launch
  • Prioritize external visibility, commitment and engagement, go beyond financial backing and enter dedicated alliances with advocacy groups (i.e. to help educate nonprofits on running their operations to sustainably support patient needs)
  • Conduct outreach initiatives and a serious of authentic interactions to deepen bonds between patient groups and your teams

BMS Teresa Bitetti SVP Head US Oncology BMS

How to Do Digital Differently: The "3D"-Script for Pharma Marketing
  • Discover how to effectively engage with patients when it matters most; design customer experiences that align content and media to build real relationships, deliver experiences consistently and superbly
  • Go beyond the patient journey and learn how to inspire patients as they move through the care cycle of detection, diagnosis, treatment, and recovery
  • Get the most out of your commercial model, grow your organization's digital quotient and become the active sharper of patient's care

Google David Blair Head of Industry- Health Google

Make medical the link between R&D and commercial
  • Discuss how and when Medical should become involved in early-stage projects and Life-cycle management
  • Explore the important role of patient centricity as an essential foundational component for collaboration
  • Identify opportunities to improve partnership effectiveness

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

4:00PM - 4:30PM
Maximizing the Potential of Your Pipeline by Utilizing Signals Intelligence to Align with the Treatment Decision Journey and Patient Desired Outcomes
  • Improve health outcomes by uncovering real, perceived and hidden barriers that define therapeutic value.
  • Drive pipeline optimization by aligning your portfolio with patient behaviour, HCP preferences, and choices of care – all critical to a successful launch.
  • Optimize patient adherence by probing real-world attitudes and sentiment toward treatment regimens and patient engagement approaches.

Signals Kobi Gershonim Co-Founder & Chief Research Officer Signals Analytics

Talkin' About My Generation: Connecting with Boomers, Xers and Millennials Around Their Health
  • Communicating with generations that have very different styles
  • Old School Can be New School: How traditional methods can apply to new generations
  • Are you in it for the long haul? Avoiding disposable relationships and building bridges across all generations
  • Results from a recent consumer survey on generational differences and similarities

Health Advocacy Strategies Jean McCoy SVP Strategy & Innovation Health Advocacy Strategies

Identifying HCPs by Name at Your Website

What happens when you solve the 20 year old problem of anonymous visitors to your website? You get:

  • An entirely new level of visitor insight
  • The ability to deliver truly customized and relevant content and services
  • The ability to extend an engagement beyond just a website session
  • A completely new approach to ROI calculation

In this session we will present data from a range of pharma sites who are answering these exact questions.

DMD Marketing David Reim Chief Product Officer DMD

The Good, The Bad and the Necessary
  • A review of success rates in recent drug launches
  • Look at where launches haven't gone well and where RWE could have played a role in mitigating this… The Bad
  • Building an Integrated Medical Plan to prepare for success. “Begin with the End in Mind”… The Good
  • The resource versus demand challenge and the consequent benefit of outsourcing… The Necessary

INC Research Janet Baldwin Vice President, Real World and Late Phase INC Research

4:30PM - 5:10PM
Panel: In our new landscape, how do we now know if a rep is successful?
  • How to define the KPIs that are needed to track sales rep performance, and push the rep to focus on the patient instead of the metrics
  • Reward your reps for prioritizing what your customer really want, and satisfy their long term objectives
  • Determine exactly what new talents are needed in order to tighten the requirements for training and avoid waste or duplication of effort

UCB David Fortanbary US Commercial Lead, Performance Training UCB

Roche Diabetes Care Jay Graves Vice President of Sales Roche Diabetes Care

Panel: Partner with your patients to develop novel patient-reported outcome (PRO) assessment tools
  • Use PRO to understand not only what's the matter with patients but what matters to your patients
  • Hear survey data from patients as to how to effectively collect PRO, leverage patient groups for PRO qualification and draw on patient-led data collection in the design of novel PROs
  • Improve PRO reliability around primary endpoints to facilitate labeling claims and approval, increase patient satisfaction and compliance

Alzheimer's Disease International Kate Gordon Policy Advisor Alzheimer's Disease International

Pfizer Roslyn Schneider Global Patient Affairs Lead Pfizer

Luck Fupus MarlaJan Wexler Patient, Lupus Advocate and Blogger Luck Fupus

Panel: The Power of Integrating Digital across all aspects of your organization
  • Discover the benefits of a customer experience that's continuously supported through digital channels
  • Maximize commercial profitability by employing new digital capabilities to support your business objectives, and set yourself apart from other mHealth offerings
  • Optimize the current digital capabilities and align them with the functions of traditional channels to stay ahead of the game

TEVA Christopher Pitcherella Director, Clinical Trial Innovation | Global Clinical Operations TEVA

Johnson & Johnson Joshua Palau Senior Director Digital Innovation, Social Media and Search Johnson & Johnson

Joyce Ercolino Digital Business Leader & Strategist  

softserve Matt Kollmorgen Vice President of Digital Transformation Group Soft Serve

Panel: Define a new Medical operating model to align with Commercial, Market Access and R&D
  • Understand what internal stakeholders think about their relationship with Medical and the emergence of Medical as a strategic partner
  • Where should medical reside - independently, within R&D, or Commercial?
  • Create a reporting and management structure that meets the needs for a new approach to Medical Affairs

GlaxoSmithKline Kate Knobil Chief Medical Officer, Pharmaceuticals GSK

Medical Affairs Professional Society Kirk Shepard President Medical Affairs Professional Society;
Eisai Pharma & Senior Vice President, Head of Global Medical Affairs Oncology Eisai Pharma

Amgen Rosh Dias Vice President, Global Scientific Affairs Amgen

5:10PM - 5:40PM
The Future-Proof Commercial Team

In this session, we will discuss industry feedback and thought leadership on:

  • The impact of patient-centric transformation on the industry, and organizational barriers to transformation
  • The relationship between patient centricity and commercial models and expectations for future needs
  • The role of technology in enabling continuous evolution and agility across the organization

Pegasystems Ed Chase Business Line Leader, Life Sciences Pegasystems

Delivering Results Through Patient-Centricity: A Look at What Works & Why
  • Thinking differently about what insights you truly need to become patient-centric
  • Practical and innovative ways companies are transforming the way they develop education and support programs to address patient needs
  • Discover how companies outside of pharma are transforming their businesses through customer engagement and how this can be applied to our industry

Sentient Jeff Rohwer Managing Director, Strategy & Innovation Sentient

Digital Transformation from the Inside Out and Upside Down
  • Understand how human science and culture contribute to the design and success of transformative experiences
  • Explore how successful transformation and experiences are driven by organizations whose internal presence mirrors their external presence
  • Attendees will gain a new perspective on how to guide transformation and to capitalize on their own skills to create positive transformations

Cognizant Life Sciences Will Reese President Cadient & Chief Innovation Officer Cognizant Life Sciences

Pharma Collaboration for Transparent Medical Information
  • HCPs need quick, relevant, accurate, scientifically-balanced medical information to enhance patient care
  • phactMI is a consortium comprised of MI departments of multiple pharmaceutical companies to address this need
  • phactMI.org provides an easy access “one stop” to information on drug interactions, stability/compatibility, and dosage and administration… and HCPs can contact and engage with dedicated MI specialists

phactMI Patrick Reilly CEO phactMI

5:40PM - 6:05PM
Customer excellence: the key to commercial excellence
  • Create a positive customer experience and ensure you retain them through a synchronized strategy at every touch point
  • Align the way in which you treat your customer across all areas of your organization in order to provide the most seamless experience possible
  • Blend all your channels in ensure you are speaking to your customer in one harmonious voice

EMD Serono Jon Barrett VP Oncology Marketing EMD Serono

Lessons on Understanding and Acting on Patient Concerns
  • Reveal the methods Sanofi used to systematize the acquiring of patient input, and the methods used to operationalize it
  • How does Pharma's approach align with other industries; lesson's learned?
  • Showcase how to measure the impact of acting on patient concerns, and create a continuum between research and development

Sanofi Anthony J. Yanni Global Head, Medical Intelligence and Patient Perspectives Sanofi

Leveraging Digital: Navigating Digital Trends and Technologies to Maximize Positive Outcomes for Patients
  • A look at the adoption of digital across all industries
  • Understand why digital will impact healthcare and How can patients benefit
  • What a Pharma company can do to address the digital trends and what are the emerging technologies
  • What could the pharma company of the future look like

Takeda Nicole Mowad-Nassar VP of External Collaborations Takeda

The Doctor is in (and out): Medical Affairs' evolution from an internal role to an external one
  • Understand the evolving role of medical affairs in pharma
  • Explore the benefits and challenges of using internal medical spokespeople for external communications
  • Embrace the potential for medical affairs' new role through a case study

GlaxoSmithKline Leonard Friedland Vice President, Director Scientific Affairs and Public Policy, Vaccines North America GSK

6:05PM - 7:30PM
Exhibition & Networking

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Day Two

Customer Experience
Digital Transformation
Commercial Model Innovation
Medical Affairs
8:30AM - 8:35AM
Chairman Opening
Chairman Opening
Chairman Opening
Chairman Opening
8:35AM - 9:00AM
Session begins at 9am – please join another room
Create a winning partnership through collaboration and innovation
  • Explore how the partnership with technology companies can revolutionize your business model and boost commercial success
  • Understand how you can advance your patient-centric model with the help of multiple players
  • See how Novartis is partnering with newer companies entering the pharma space to create value for patients

Novartis David Lennon VP & Franchise Head, US Oncology- Lung, Melanoma and Neuroendocrine Tumours Novartis

Your Company needs to be Disrupted: Leverage Corporate Activism for Quality Control and Value Creation
  • When tweaking no longer cuts it: Hear why Sanofi decided to take unprecedented steps to address quality issues through a business transformation rooted in collaborative tools and technologies
  • Incubate change wherever you sit: Hear views from both floor staff and executives how to disrupt a company and re-ignite productivity with tools of behavioural change and social engagement
  • Securing Buy-In: How to manage executive support, show metrics and convince your leadership to embrace the power of diverse networks to once-and-for-all replace pharma's (patriarchal) corporate hierarchies

Sanofi Pasteur Christine Richards Director SP Quality Academy Sanofi Pasteur

Collaborate with Commercial to create a compliant and patient-focused Medical Affairs strategy
  • Identify appropriate cross-functional stakeholders for coordination and alignment
  • Ensure independence and integrity of Medical Affairs and Commercial functions
  • Enable effective and compliant information sharing/communication

Astellas Pharma Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas Pharma

Astellas Karen Lowney Executive Director, Global Compliance, Privacy & Transparency Astellas

9:00AM - 9:30AM
What’s in a name?
  • Explore why your name is critical to the success of your brand
  • Learn about the .health extension that launches this July

Followed by a panel discussion with:

  • Erin Byrne, Chief Client Officer at greyhealth group
  • Melissa Lederer, Head of Marketing at MATTER
  • Matthew Murphy, Director of Digital Health Innovation at Boston Children's Hospital
  • José Ignacio Rasco, CEO at dotHealth

dotHealth José Ignacio Rasco CEO .health

The Freedom to Fail: Using predictive analytics to simulate, experiment with and optimize your approach to marketing
  • Test it before you try it by using simulation-based modeling
  • Arm yourself with the data to validate new approaches
  • Stop investing in things only because ‘we did it last year'
  • Move from instinct to evidence as you plan for 2018

inVentiv Health Communications Patrick Richard Managing Director Data Science inVentiv Health Communications

inVentiv Health Communications Leigh Householder Managing Director of Innovation inVentiv Health Communications

Challenging pharma's traditional sales model to drive revenue, access, and customer experience
  • Learn about a service model which has proven an increase in revenue across the lifecycle of a brand
  • Access to targeted accounts reach nearly 100%
  • A clear mission to serve patients improves job satisfaction and retention among service representatives
  • Proven value to patients, physicians and office staff over traditional representatives

Ashfield John Gerow Global Head, Customer Service Model Ashfield

Hire the right skillsets for the new medical affairs paradigm
  • Define recruitment and training strategies to meet your medical affairs needs
  • Build soft business skills within medical specialist talent
  • Create a team that can execute RWE and data-centric engagement strategies

- Stanislev Glezer former Vice President, Medical Affairs Novo Nordisk

9:30AM - 9:55AM
Sales rep 2.0: A new portrait of a customer facing role
  • Upskill your rep to make the most of every customer interaction, in order to not waste any time and ensure commercial success
  • Define the role the new rep has to take in order to support new growth and training
  • Identified gaps in your field force in order to ensure you have the strongest team when facing the customer

Roche Diabetes Care Jay Graves Vice President of Sales Roche Diabetes Care

Listen to what the patient is saying- they are after all depending on you.
  • Utilize patient data to make more informed commercial strategy decisions
  • Leverage insights from the front lines: Re-define patient focus as customer service and strategically optimize patient engagement and field-based promotions based on front-line experiences
  • Hear how patient input can add value and profitability to your customer interactions and without a doubt improve patient outcomes

Alnylam Pharmaceuticals Mark Baglin Vice President of Global Marketing Alnylam Pharmaceuticals

Seize the day: teach your commercial teams to leverage untapped opportunities with patient-centric selling
  • Collaborate with different internal partners and stakeholders, in order to ensure that customer engagement interactions are impactful to the customer
  • Become an educator alongside your selling, build trust and improve patient engagement
  • Case Study: A look at value over volume selling, a new kind of customer engagement.

Takeda Pharmaceuticals USA Heather Dean National Head Specialty Sales & Accounts Takeda Pharmaceuticals USA

The Competent Medical Affairs Professional
  • Discuss the emerging role of professional competencies (applied knowledge, skills and behaviors) in bridging the business needs with the scientific rigor of the medicines development process
  • Understand how to benchmark the proposed competency profiles in medical affairs
  • Appreciate the value of a multi-sectorial collaboration (academia, professional associations, pharmaceutical industry) to improving performance in the Medical Affairs function

IFAPP Honorio Silva President IFAPP

9:55AM - 10:20AM
Patient-Centricity…A practical approach for implementation at a brand and corporate level
  • Apply patient-centric approaches to brand planning
  • Facilitate cultural mindset shift by setting a corporate framework for patient-centricity
  • Prioritizing quick wins and longer term approaches for transformational change

Sunovion John Jacoppi Executive Director New Product Planning Sunovion

Maximize the capabilities of your commercial teams through a greater understanding of Analytics, CRM and CLM
  • Leverage the insights gained from analytics, CRM and CLM for a more personalized interaction
  • Revolutionize sales performances, by increasing value to HCPs by responding to market changes and prescribing habits
  • Develop a segmentation strategy informed by data to ensure you're personalizing your interactions with your customer and content

Abbvie Laura Barry Senior Director Customer Insights, Analytics and Experiences Abbvie

Customer-Centricity is key, are you doing enough?
  • Embed a customer-centric mindset across the whole organizations and across all commercial functions to add value and improve retention and resources for them and patients
  • Become the kind of partner your organized customer wants, and work together towards solutions for outcome optimization and improved patient experience
  • Create a cultural mind-shift in your organization that puts impactful customer programs and services first

Astellas Peter Sandor Head of Oncology Marketing Astellas

How to create a patient-centric Medical Affairs unit
  • Define best practice to engage patients, understand their needs and create patient-centric medical information exchange
  • How to work progressively with patients to gather data
  • Can Medical Affairs become the patient centricity function?

Pfizer Roslyn Schneider Global Patient Affairs Lead Pfizer

10:20AM - 10:40AM
Exhibition & Networking Coffee Break
Customer Experience
Pharma's Triple Aim
Commercial Model Innovation
Medical Affairs
10:40AM - 11:20AM
Panel: Differentiate your offerings through co-creation and superior customer experience
  • Meet customer and patients need, provide unique offerings and get yourself ahead in the marketplace
  • Drive sustained engagement through co-creation of patient support programs and superior consumer experience
  • Hear from a panel of commercial leaders how to define the relationship between business strategy and patient focus

Sanofi Pasteur Kasia Hein-Peters Vaxelis (PR51) Marketing Head Sanofi Pasteur

Speaker_Logo Heidi Floyd Author / Patient / Advocate / Speaker  

Aqua Pharmaceuticals Jim DeMaioribus Vice President Aqua Pharmaceuticals

Panel: ‘Where Rubber hits the Road': Move from words to actions on Patient Centricity
  • Move from “Why” to “How to” and realize patient centricity not just out of moral obligation, but as a core objective for your organization
  • Discover how your teams can reach the ‘sweet spot' between patient and profit, achieving high trust and credibility, business growth and better outcomes for all

Johnson & Johnson Ramana Sonty Director- Global Medical Organization Johnson & Johnson

Pfizer Inc Nisith Kumar Director, Global Patient Affairs Pfizer Inc

Global Alzheimer's Platform Foundation Kate Zhong Chief Strategy Officer Global Alzheimer's Platform Foundation

Tonic Life Communications Maryellen Royle Global CEO Tonic Life Communications

Panel: A holistic commercial view: integrate your sales and marketing teams in order to achieve true commercial excellence
  • Take your business to the next level with common objectives and incentives to promote a collaborative culture across sales and marketing
  • Encourage sales and marketing to align their common interests and impact and influence behavioural change within your organization
  • Speak with one voice: Integrate M&S in order to work in synch with your customers' needs
  • Supplement commercial functions, with foresights and forecasting to help them know what will actually benefit the patient
  • Aligned the skills of your customer facing roles so that you approach customer engagement strategy with a unified front

Shire Chris Sellin Head of Operational Excellence & Analytics Shire

Zephyr Health William King Founder Zephyr Health

Takeda Pharmaceuticals USA Heather Dean National Head- Specialty Sales & Accounts, Specialty Business Unit Takeda Pharmaceuticals USA

Panel: Proactive communication of scientific and health economic information
  • Expert legislative and regulatory guidance relating to scientific communication by medical affairs personnel
  • An update on FDAMA 114 and the proactive communication of health economic information
  • Recent changes to communication of scientific and health economic information of pipeline products and indications
  • Recommendations from the Academy of Managed Care Pharmacy Partnership Forum on Pre-approval Information Exchange

Genentech Dana Evans Director for Patient Access, Collaboration and Exchange Genentech

Aetna Elizabeth Engelhardt Head of Specialty Strategy & Clinical Management Aetna

Academy of Managed Care Pharmacy (AMCP) Soumi Saha Assistant Director of Pharmacy & Regulatory Affairs Academy of Managed Care Pharmacy (AMCP)

11:20AM - 11:50AM
The Rise Of Consumerism In Healthcare: Engaging Your New Customer
  • The rise of consumerism in healthcare and its implications on your patient engagement strategy
  • A proven approach for going beyond the pill to engage patients as active participants in their care
  • The importance of looking to other industries that are already delivering 1:1 customer experiences
  • The future of the industry - how to leverage data and analytics for hyper-personalization as well as new innovations including artificial intelligence and voice

Mobiquity Ashkan Afkhami VP & GM, Healthcare Mobiquity

Mobiquity Mike Welsh Chief Creative Officer Mobiquity

Delivering Value through Patient Centric Transformation
  • Discuss how to be adequately prepared across the commercial continuum for Market Access and Pricing evolution that is rapidly moving toward more value based, outcomes driven solutions.
  • Understand how to stand out based on Patient services programs that are increasingly the differentiating factor driving patient centricity and greater customer experience.
  • Learn how your organization can be better positioned within a multi-stakeholder, patient-centric, digitally enabled environment.

EY Susan Garfield Principle EY

Innovation in Provider Access: A New Era of Outcomes
  • Identify the current challenges presented to field forces by the face-to-face push sales model given decreased access with healthcare providers.
  • Explore and discuss the new solutions that add pull to sales efforts and early successes of these solutions.
  • Discuss the potential for the future. How can the life sciences further diversify their channels? What other pressing HCP and life science issues can be solved using technology?

Outcome Health Roger Sawhney Senior Vice President of Life Sciences Strategy and Business Development Outcome Health

Can Medical Affairs stay relevant in an era of emerging technologies to help the HCP?
  • Appreciate how healthcare professionals' disease information needs are changing
  • Can technology help Medical to stay relevant, and meet increasingly high expectations of HCPs, or will it become a competitor?
  • Envisage what the future of medical could look like in this rapidly changing world of technology

Bristol-Myers Squibb Lav (Bobby) Parvathenani Specialty Medical Information Lead, US Medical Bristol-Myers Squibb

11:50AM - 12:50PM
Exhibition, Networking & Work Lunch Roundtables
11:50AM - 12:50PM
Interactive Roundtables – Lead the discussion

Moderated by industry experts, you can join fellow attendees in one of 5 interactive roundtables providing you with the opportunity to go in-depth into the challenges which you’re faced with on a daily basis – you guide the agenda.


Diversity is an Opportunity: the benefits of engaging with diverse patient populations across R&D and commercial strategies

  • Discuss how to reach out to patient communities of all backgrounds
  • Improve your understanding of the needs of patients from all backgrounds, to develop support services that meet those needs at the site of care

Moderated by: Melva Covington, Senior Director, Head of Field Based Medical Strategy, Sanofi

Felicia S. Johnson, Patient Advocate


Digital Health Marketing – Challenges, Opportunities and Best Practice

  • Join industry leader, Mark Bard, co-founder of the Digital Health Coalition in an open discussion on the future of digital health marketing
  • Learn from your peers on the nuances of the existing landscape including market trends, regulatory concerns (and solutions) and best practice examples.

Moderated by: Mark Bard, co-chair and founder, Digital Health Coalition


Redefining Sales Operations as a Strategic Function

  • Discuss research from the Sales Management Association on how high-performing sales operations functions define objectives, allocate resources and maximise quality and efficiency
  • Hear how to redefine of sales operations to become a strategic imperative, not just a tactical function

Moderated by: Bob Kelly, chairman, The Sales Management Association


Leave the Silo: Fostering Cross-Company Partnerships to Deliver Real Change for Patients

  • Join a discussion on how as an industry we can join together to drive real change
  • Hear about how The Aurora Project is helping to guide patient-centric change across pharma and what you can do to get involved

Moderated by: Jill Donahue, co-founder of The Aurora Project


Women in Pharma

  • Join industry leader, Laurie Cooke, CEO of the Healthcare Businesswomen’s Association in an open discussion on women in Pharma
  • Gender Diversity is no longer a women’s issue, it’s a business issue. Business can get there faster by partnering; greater partnership means greater progress.

Moderated by: Laurie Cooke, CEO, Healthcare Businesswomen's Association


Medical Affairs: Education and Training for an effective performance

  • Discuss the professional competencies for biomedical professionals to leverage their contributions within the organization
  • Discuss the initiatives developed by IFAPP and King’s College London for professional certification in Medical Affairs

Moderated by Honorio Silva, President, IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine)

12:50PM - 1:20PM
The Modern Marketer: how to stay ahead in a competitive and evolving landscape
  • Work cross-functionally with your teams to maximize your commercial capabilities
  • Become a reliable supplier and valuable partner to your customers
  • Understand how to identify areas of mutual gain with IDNs to help improve patient outcomes and reduce costs

GSK Kim Murphy VP Global Vaccines Commercialization Leader- Influenza GSK

Proactive Nurse Engagement to Improve the Patient Experience: The UCB Right Start Program Case Study
  • Understand the difference a trusted advocate can make in addressing the unmet needs of patients with chronic conditions throughout their healthcare journey
  • Learn how engaging Nurse Educators to connect patients with the right resources at the right time provided a superior experience and improved patient persistency

UCB Jamie Burks Patient Experience Lead, Patient Value Unit UCB

BLANK Liza Maricle RN, Right Start Nurse Educator  

How Lilly Drives Efficiency and Business Insights through Advanced Forecasting Methodologies

Through this case study example, discover how this leading pharmaceutical organization leveraged advanced Forecasting methodologies and tools to:

  • Increase the Productivity of the Forecasting team
  • Reduce the time to create a forecast by more than 50%
  • Analyze large amounts of data quickly and with more accuracy using advances in technologies
  • Manage multiple data sources, forecasting tools and performance reporting in one common system

Eli Lilly and Company Robert P Draper Sr Director, Lilly BioMedicines Forecasting Eli Lilly and Company

Make companion diagnostics a reality with more collaborative medical & scientific affairs
  • Discover how a coordinated approach between pharmaceutical and diagnostic medical affairs will lead to successful and rapid adoption of a companion diagnostic
  • Identify the various factors influencing the use of a companion diagnostic, and how this then influences the use and performance of the companion therapeutic
  • How to develop an implementation strategy that assures access to the companion diagnostic test at the day of drug launch

Roche Diagnostics Alan Wright Chief Medical Officer Roche Diagnostics

1:20PM - 1:45PM
Session ends. Please join another room
Why Highly Effective Drugs Are Not Enough: An Affordable Solution to Eliminating HCV
  • Develop responses to the problem of undiagnosed Hepatitis C cases globally, and learn that high drug prices are financially toxic to payers and patients and disincentives screening for undiagnosed patients
  • See how Trek is developing affordable and accessible HCV Genotype 1b (G1b), G1, and G2/3 Regimens for under-served populations in middle- and high-income countries  

TREK Therapeutics Ann Kwong CEO TREK Therapeutics

Session ends. Please join another room
Execute a MSL strategy that navigates pro-active engagement and compliance
  • How to add customer value beyond communicating product information
  • Where should you invest to create impactful resources in a landscape of competitive sources of disease information?
  • Learn what steps to take to mature your model of MSL engagement

GlaxoSmithKline Diane McDowell Head, Global Scientific Affairs Oncology GSK

1:45PM - 2:50PM
Pharma-only Workshops

Hosted by:

viihealth, Clarkston Consulting

Vii Health
Clarkston Consulting
Panel: RWE Excellence within Medical Affairs
  • With the deluge of possible RWE sources, how do we develop analytic tools to assess the value of data
  • How can Medical Affairs facilitate the generation of new data?
  • How has the growth in evidence sources changed the importance of KOLs?
  • What compliant strategies can Medical Affairs use to communicate RWE?

Moderator: ghg_greyhealth_group Lynn Vos CEO ghg | greyhealth group

Astellas Shontelle Dodson Vice President, Medical Excellence/Medical Affairs Global Astellas

Sanofi Genzyme Paul Rowe Vice President, Global Medical Affairs Head, Airway/Respiratory Sanofi Genzyme

- Stanislav Glezer Former Vice President, Medical Affairs Novo Nordisk

2:50PM - 3:10PM
Exhibition & Networking Coffee Break
Keynote Closing
3:10PM - 3:20PM
Awards Finalist: Customer Innovator Award & Lifetime Achievement Award
3:20PM - 3:50PM
The Impact of Value-Based Care: How It Will Transform Your Commercial Model
  • Explore the evolution of value-based care in the current healthcare ecosystem
  • Prepare to address the intersection of patient consumerism and value-based care to support a new definition of success
  • Examine key considerations to improve commercial uptake in a value-based care environment

McKesson Reagan Tully VP Marketing and Strategy McKesson

3:50PM - 4:20PM
Squaring the Circle: how to drive performance and create success in a values culture
  • Explore the complex launch challenges faced by GSK's newest vaccine Bexsero
  • Find out how GSK integrated Novartis Vaccines in its largest market, while implementing new commercial model changes in terms of HCP interaction
  • Understand how Patrick Desbiens led the integration of legacy and new vaccines teams and created a launch plan
  • Listen to Patrick explain the choices and the learnings on how to achieve success in a strong value-based culture from a year that saw GSK's vaccine sales in the US increase by 12%

GSK Patrick Desbiens Senior Vice President, US Vaccines GSK

4:20PM - 4:30PM
Awards Finalist: Most Valuable Pharma Collaboration
4:30PM - 5:00PM
The Implementation Panel: From Words to Action, How to Become a Pharma Intrapreneur
  • Hear from our panel how you can make actionable change in your organizations through a structured process, behavioral engagement and prospective resource planning
  • Ensure open and reliable communication streams between departments, learn practical steps to break the ‘silo mentality', and institute a collaboration approach that removes barriers long before they become a threat
  • Become the ‘Intrapreneurial change agent' everyone respects, form alliances and manage innovation processes effectively to strengthen your organization from within

GSK Cheryl MacDiarmid SVP & Business Unit Head, Primary Care GSK

Sanofi Sheldon Koenig SVP & Head Cardiovascular Franchise Sanofi

Moderator eyeforpharma Paul Simms Chairman eyeforpharma

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription